JTR-161

N/A

Report date: 2022/11/05 14:14:16

Base Information

Drug NameJTR-161

Drug Alias NameDental pulp stem cellsDPCsJTR-161

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Dental pulp stem cell therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsIschemic Stroke

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesJcr Pharmaceuticals Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesTeijin Pharma Ltd

Inactive CompaniesN/A

Active IndicationsIschemic Stroke

Inactive IndicationsN/A

Other Information

ATC CodeN/A